Byrd Jay J, White Andrew C, Nissen Claire G, Schissel Makayla, Van Ormer Matthew, Velasco Danita, Wallace Maegen
College of Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, United States.
The Child Health Research Institute, University of Nebraska Medical Center, Omaha, NE, 68198, United States.
JBMR Plus. 2024 Sep 30;8(11):ziae125. doi: 10.1093/jbmrpl/ziae125. eCollection 2024 Nov.
Osteogenesis imperfecta (OI) is an inherited disorder characterized by bone fragility with extraskeletal manifestations mostly due to and variants. Currently, 23 genes have been implicated in the pathogenesis of OI; however, literature on genotype-phenotype correlation and incidence of non-skeletal clinical features are limited. This study aims to identify genotype-phenotype correlations in patients with OI, allowing clinicians to better inform families of prognosis, optimize patient care, and facilitate evidence-based clinical decision-making. We retrospectively reviewed 294 patients with OI to collect demographic data, clinical characteristics, and genotypic information. Patients were stratified by vs non- variants to evaluate differences in phenotype. The majority of OI was due to variants in (91%), with the remaining 9% due to non- variants. Most patients in the group were White compared to the non- group (78% vs 50%; = 0.004). 2 patients had higher incidence of blue sclerae (83% vs 58%, = 0.002), dentinogenesis imperfecta (49% vs 15%, < 0.001), and family history of OI (34% vs 12%, = 0.03). Those in the non- group have higher rates of scoliosis compared to those in the group (62% vs 40%, = 0.04), as well as higher rates of expressive language disorder/delay (15% vs 0.4% in non- and patients, respectively; < 0.001). Identifying the underlying molecular etiology early is imperative for optimal clinical care, allowing for appropriate risk counseling, identification of affected relatives, and improved anticipatory care and management. These data support that rare subtypes of OI occur more frequently in non-White individuals and demonstrated genetic associations with incidence of blue sclera, dentinogenesis imperfecta, scoliosis, and expressive language disorders.
成骨不全症(OI)是一种遗传性疾病,其特征为骨骼脆弱并伴有骨骼外表现,主要由[基因名称1]和[基因名称2]变异引起。目前,已有23个基因与OI的发病机制相关;然而,关于基因型-表型相关性以及非骨骼临床特征发生率的文献有限。本研究旨在确定OI患者的基因型-表型相关性,以便临床医生能更好地向患者家属告知预后情况、优化患者护理并促进基于证据的临床决策。我们回顾性分析了294例OI患者,收集人口统计学数据、临床特征和基因分型信息。根据[基因名称1]变异与否对患者进行分层,以评估表型差异。大多数OI病例由[基因名称1]变异引起(91%),其余9%由非[基因名称1]变异引起。与非[基因名称1]变异组相比,[基因名称1]变异组中的大多数患者为白人(78%对50%;P = 0.004)。[基因名称1]变异组中有2例患者出现蓝色巩膜的发生率更高(83%对58%,P = 0.002)、牙本质发育不全的发生率更高(49%对15%,P < 0.001)以及有OI家族史的比例更高(34%对12%,P = 0.03)。与[基因名称1]变异组相比,非[基因名称1]变异组患者的脊柱侧凸发生率更高(62%对40%,P = 0.04),以及表达性语言障碍/延迟的发生率更高(非[基因名称1]变异组和[基因名称1]变异组患者分别为15%和0.4%;P < 0.001)。早期确定潜在的分子病因对于优化临床护理至关重要,这有助于进行适当风险咨询、识别受影响亲属并改善预期护理和管理。这些数据支持OI的罕见亚型在非白人个体中更频繁出现,并证明了与蓝色巩膜、牙本质发育不全、脊柱侧凸和表达性语言障碍发生率的遗传关联。